Utah Medical Products, Inc. (NASDAQ:UTMD – Get Rating) Director Barbara A. Payne sold 2,000 shares of the stock in a transaction that occurred on Wednesday, May 11th. The stock was sold at an average price of $85.20, for a total value of $170,400.00. Following the completion of the transaction, the director now directly owns 5,338 shares of the company’s stock, valued at $454,797.60. The sale was disclosed in a filing with the SEC, which is available at this link.
Shares of UTMD opened at $83.89 on Friday. Utah Medical Products, Inc. has a 1 year low of $81.01 and a 1 year high of $133.87. The stock has a 50 day simple moving average of $87.32 and a 200-day simple moving average of $95.45. The stock has a market cap of $306.62 million, a PE ratio of 20.07 and a beta of 0.25.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 6th. Stockholders of record on Friday, June 17th will be issued a $0.29 dividend. The ex-dividend date is Thursday, June 16th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 1.38%. Utah Medical Products’s payout ratio is presently 27.75%.
A number of hedge funds have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC increased its holdings in Utah Medical Products by 0.4% during the 1st quarter. Renaissance Technologies LLC now owns 223,714 shares of the medical instruments supplier’s stock valued at $20,103,000 after purchasing an additional 800 shares in the last quarter. Ancora Advisors LLC increased its holdings in Utah Medical Products by 51.1% during the 1st quarter. Ancora Advisors LLC now owns 40,338 shares of the medical instruments supplier’s stock valued at $3,494,000 after purchasing an additional 13,649 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Utah Medical Products by 2.1% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 14,862 shares of the medical instruments supplier’s stock valued at $1,336,000 after purchasing an additional 304 shares in the last quarter. Lazard Asset Management LLC increased its holdings in Utah Medical Products by 21.3% during the 1st quarter. Lazard Asset Management LLC now owns 837 shares of the medical instruments supplier’s stock valued at $75,000 after purchasing an additional 147 shares in the last quarter. Finally, LSV Asset Management acquired a new stake in Utah Medical Products during the 1st quarter valued at $1,177,000. 71.44% of the stock is owned by hedge funds and other institutional investors.
Utah Medical Products Company Profile (Get Rating)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
- Get a free copy of the StockNews.com research report on Utah Medical Products (UTMD)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.